drugset / Trial / NCT07674680
Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women
RandomizedCrossoverSingle-blindBasic science
Summary
We hypothesize vascular beta3 adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and enhance vascular function in aging women.
Timeline
- Start
- 2026-07
- Primary completion
- 2028-05
- Completion
- 2029-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vibegron | Unknown | 75 mg | Oral |
Indications
No indication recorded.